This statistic shows the distribution of domestic research and development expenditure of pharmaceutical companies in France in 2017, in millions of euros. At that time, French pharmaceutical companies spent almost 1.4 billion euros on applied research.
Domestic expenditure on research and development of pharmaceutical companies in France in 2017 * (in millions of euros)
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Total R&D expenditure of French pharmaceutical companies 2017
- Basic Statistic Percentage of select global funders for tuberculosis research and development 2022
- Basic Statistic Total turnover of the French medicines market 2010-2018
- Basic Statistic Distribution of the turnover of the pharmaceuticals market in France 2017, by segment
- Basic Statistic Total prescription drug revenue in Europe from top 10 companies 2015
- Premium Statistic Number of employees in R&D of pharmaceuticals companies in Italy 2008-2020
- Premium Statistic Production price of pharmaceuticals on domestic market in Italy 2005-2021
- Premium Statistic Sales revenue of JW Pharmaceutical 2014-2022
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
About the region
10
- Basic Statistic Number of employees of pharmaceutical companies by region France 2020
- Basic Statistic Breakdown of the workforce of Sanofi 2018, by geographical location
- Basic Statistic Sanofi's workforce in 2018, by segment
- Basic Statistic Companies in the manufacture of pharmaceutical products in France 2009-2020
- Basic Statistic Turnover of medicines distributed in hospitals in France 2010-2018
- Premium Statistic Share of generic drugs in the pharmaceutical market in France 2018
- Premium Statistic Belief that the toxicity of vaccines is covered up by the government in France 2018
- Basic Statistic Total consumption of antibiotics in France 2000-2016
- Premium Statistic Volume share of the generic pharmaceuticals market in France 2004-2015
- Basic Statistic Breakdown of employees of drug companies by age France 2014
Selected statistics
6
- Premium Statistic Pfizer's ad spending 2006-2023
- Premium Statistic Number of employees at Sinopharm 2011-2022
- Premium Statistic Revenue of Sinopharm 2011-2022, by category
- Premium Statistic Annual revenue of Sinopharm 2010-2022
- Premium Statistic Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Basic Statistic M&A capacities - changes for the global pharma industry 2008-2015
Other regions
10
- Premium Statistic Research and development in European pharmaceutical industry by country 2021
- Premium Statistic Number of total approvals by top pharmaceutical companies 2017
- Premium Statistic Number of registered COVID-19 studies worldwide Apr 2020 - Dec 2022, by region
- Basic Statistic Illinois' medical cannabis sales value U.S. 2018-2024
- Premium Statistic Colorado's medical cannabis spending 2018-2024
- Basic Statistic Maine's medical cannabis spending 2018-2024
- Premium Statistic Massachusetts' medical cannabis spending 2018-2024
- Basic Statistic Oregon's medical cannabis sales value U.S. 2018-2024
- Basic Statistic Vermont's medical cannabis sales value U.S. 2018-2024
- Premium Statistic Latin America: per capita sales of OTC medicines 2017, by country
Related statistics
10
- Basic Statistic Average cost of hospital per day by country 2015
- Basic Statistic Ipsen group sales 2019, by therapeutic area
- Basic Statistic Number of opioid and naloxone prescriptions in the U.S. 2018, by prescriber specialty
- Basic Statistic Rate of naloxone prescriptions per 100 opioid prescriptions U.S. 2018, by prescriber
- Premium Statistic Botulinum toxin facial rejuvenation market size worldwide from 2016-2026
- Premium Statistic Soft tissue fillers facial rejuvenation market size worldwide from 2016-2026
- Premium Statistic Chemical peel facial rejuvenation market size worldwide from 2016-2026
- Premium Statistic Boiron laboratories turnover in France 2022, by region
- Premium Statistic Global turnover of Boiron laboratories 2012-2022
- Premium Statistic Worldwide workforce of Boiron laboratories 2022, by gender
Further related statistics
10
- Merck & Co total assets 2009-2023
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Medicinal market growth worldwide including rebates 2009-2018
- AstraZeneca's expenditure on research and development 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Johnson & Johnson's number of employees 2004-2023
Further Content: You might find this interesting as well
Statistics
- Merck & Co total assets 2009-2023
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Medicinal market growth worldwide including rebates 2009-2018
- AstraZeneca's expenditure on research and development 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Johnson & Johnson's number of employees 2004-2023
LEEM. (July 23, 2020). Domestic expenditure on research and development of pharmaceutical companies in France in 2017 * (in millions of euros) [Graph]. In Statista. Retrieved March 28, 2024, from https://www.statista.com/statistics/771231/expenses-inland-research-and-development-business-drugs-la-france/
LEEM. "Domestic expenditure on research and development of pharmaceutical companies in France in 2017 * (in millions of euros)." Chart. July 23, 2020. Statista. Accessed March 28, 2024. https://www.statista.com/statistics/771231/expenses-inland-research-and-development-business-drugs-la-france/
LEEM. (2020). Domestic expenditure on research and development of pharmaceutical companies in France in 2017 * (in millions of euros). Statista. Statista Inc.. Accessed: March 28, 2024. https://www.statista.com/statistics/771231/expenses-inland-research-and-development-business-drugs-la-france/
LEEM. "Domestic Expenditure on Research and Development of Pharmaceutical Companies in France in 2017 * (in Millions of Euros)." Statista, Statista Inc., 23 Jul 2020, https://www.statista.com/statistics/771231/expenses-inland-research-and-development-business-drugs-la-france/
LEEM, Domestic expenditure on research and development of pharmaceutical companies in France in 2017 * (in millions of euros) Statista, https://www.statista.com/statistics/771231/expenses-inland-research-and-development-business-drugs-la-france/ (last visited March 28, 2024)
Domestic expenditure on research and development of pharmaceutical companies in France in 2017 * (in millions of euros) [Graph], LEEM, July 23, 2020. [Online]. Available: https://www.statista.com/statistics/771231/expenses-inland-research-and-development-business-drugs-la-france/